ArticleCancer immunology research2025

TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids.

Yi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.